• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-6.0-60-PTX
Device Problem Occlusion Within Device (1423)
Patient Problem Reocclusion (1985)
Event Date 06/02/2014
Event Type  Injury  
Manufacturer Narrative
(b)(4).As 3 stents are suspected to be involved in this event a separate report has been submitted for each suspect device.Reference also reports # 3001845648-2017-00607 and 3001845648-2017-00608.This investigation will capture the restenosis of ziv6-35-125-6.0-60-ptx stent of lot number c778439.The ziv6-35-125-6.0-60-ptx stent of lot number c778439 was implanted in the patient and is therefore unavailable for evaluation.With the information provided a document based investigation was carried out.The patient had the following pre-existing conditions: coronary artery disease, hypertension, diabetes, hypercholesterolemia, ever smoked.Pad (peripheral artery disease).It was stated in the complaint file that no imaging was available for review, and cri stated they currently had no imaging for review for this patient.There is no evidence to suggest that this event did not occur, therefore the complaint is confirmed based on customer testimony.Restenosis is a common adverse event of endovascular procedures and can be caused by injury to the vessel (e.G.During percutaneous transluminal angioplasty (pta) and/or stenting).Vessel injury provokes an inflammatory response that leads to (or amplifies) the restenosis process.It may be noted that surface of the zilver ptx stent is coated with the drug (paclitaxel) to help prevent subsequent restenosis of the artery.It can be therefore stated that it is very unlikely that the reported restenosis could have occurred due to zilver ptx malfunction; however as no imaging was available at the time of investigation, a definitive root cause of this event cannot be determined at this time.It may be noted that the packaging insert lists restenosis of the stented artery as a known potential adverse event associated with placement of this device.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant manufacturing records revealed no discrepancies that could have contributed to this complaint.Upon review of complaints, this failure mode has occurred previously with the lot number c778439.However based on the information available to date, there is no evidence to suggest that there are any manufacturing issues associated with the lot number c778439.New medication(s) was/were prescribed under physician¿s decision and administered to the patient.It is unknown what medicine was newly administered.The patient has not recovered.Complaints of this nature will continue to be monitored for any potential emerging trends.
 
Event Description
On (b)(6) 2012: three ptx stents were placed from the left sfa ~ popliteal artery above the knee.On (b)(6) 2014: restenosis or 100% restenosis was confirmed.Date unknown: medication(s) was/were changed.On (b)(6) 2017: the patient has not recovered.Clarification was requested regarding "medication(s) was/were changed." the following was received: "new medication(s) was/were prescribed under physician¿s decision and administered to the patient.It is unknown what medicine was newly administered." as 3 stents are suspected to be involved in this event a separate report has been submitted for each suspect device.Reference also reports # 3001845648-2017-00607 and 3001845648-2017-00608.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer Contact
michael galvin
o'halloran road
national technology park
limerick 
061334440
MDR Report Key7125218
MDR Text Key95186514
Report Number3001845648-2017-00606
Device Sequence Number1
Product Code NIU
UDI-Device Identifier10827002513423
UDI-Public(01)10827002513423(17)140521(10)C778439
Combination Product (y/n)N
PMA/PMN Number
P100022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 11/24/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberZIV6-35-125-6.0-60-PTX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date12/18/2017
Event Location Hospital
Initial Date Manufacturer Received 11/24/2017
Initial Date FDA Received12/18/2017
Date Device Manufactured06/19/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-